**UNITED      STATES **
**SECURITIES AND EXCHANGE COMMISSION**

**Washington,      D.C. 20549**

**FORM      10-QSB**

|   | **[**Ö**]**                                                                                                                | Quarterly                  Report pursuant to Section 13 or 15(d) of the Securities Exchange                  Act of                  1934 |   |   |
|--------|--------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|
|   |                                                                                                                                 | For                  the quarterly period ended August 31, 2007                                                                       |   |   |
|   |                                                                                                                                 |                                                                                                                                       |   |   |
|   | **                                 [   ]** | TRANSITION                  REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT                  OF                  1934      |   |   |
|   |                                                                                                                                 | For                  the transition period from _______________to                  ________________                                        |   |   |

**Commission      File No. **
**333-86706**

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

| **Nevada**                                                         |   **7389**                                                    | **98-0375957**                                    |
|--------------------------------------------------------------------|-------------------------------------------------------------------------|---------------------------------------------------|
| (State                or Other Jurisdiction of Incorporation)      | (Primary                Standard Industrial Classification Code Number) | (IRS                Employer Identification. No.) |
|                                                               |                                                                    |                                              |
| **1817                Dogwood Dr, Kokomo, Indiana 46902**          |
| (Address                of Principal Executive Offices) (Zip Code) |
|                                                               |

** (765)      456-1089**

**None**

**Common Stock, par value      $0.001 per share**

----

|                                                                                                                                  | PAGE   |
|---------------------------------------------------------------------------------------------------------------------------------------|--------|
| **PART                  I. FINANCIAL INFORMATION**                                                                                    |   |
| Item                  1. Financial                  Statements                                                                        |   |
|                       Consolidated Balance Sheets (unaudited)                                                     | 2      |
|                       Consolidated Statements of Operations (unaudited)                                           | 3      |
|                       Consolidated Statements of Cash Flows (unaudited)                                           | 4      |
|                       Notes to Financial Statements (unaudited)                                                   | 5      |
|                                                                                                                                  |   |
| Item                  2. Management’s Discussion and Analysis of Financial Condition and Results                  of Operations | 8      |
| Item                  3. Controls and Procedures                                                                                      | 11     |
|                                                                                                                                  |   |
| **PART                  II. OTHER INFORMATION**                                                                                       |   |
|                                                                                                                                  |   |
| Item                  1. Legal Proceedings                                                                                            | 12     |
| Item                  2. Unregistered Sales of Equity Securities and Use of                  Proceeds                                 | 12     |
| Item                  3. Defaults upon Senior Securities                                                                              | 12     |
| Item                  4. Submission of Matters to a Vote of Security Holders                                                          | 12     |
| Item                  5. Other Information                                                                                            | 12     |
| Item                  6. Exhibits and Reports on Form 8-K                                                                             | 12     |
|                                                                                                                                  |   |
| Signatures                                                                                                                            | 13     |

----

**FORWARD-LOOKING        STATEMENTS**

|   | o | our                ability to raise capital,                                                                  |   |
|--------|---|---------------------------------------------------------------------------------------------------------------|--------|
|   | o | our                ability obtain and retain customers,                                                       |   |
|   | o | our                ability to provide our products and services at competitive                rates,          |   |
|   | o | our                ability to execute our business strategy in a very competitive                environment, |   |
|   | o | our                degree of financial leverage,                                                              |   |
|   | o | risks                associated with our acquiring and integrating companies into our                own,     |   |
|   | o | risks                related to market acceptance and demand for our services,                                |   |
|   | o | the                impact of competitive services,                                                            |   |
|   | o | other                risks referenced from time to time in our SEC filings.                                   |   |

----

**PART      I – FINANCIAL INFORMATION**

**ITEM      1. FINANCIAL STATEMENTS**

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

**CONSOLIDATED      BALANCE SHEETS**

**(unaudited)**

|                                                                                                                                                  | August                  31,2007                                                        |   | February                  28,2007                        |
|-------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------|--------|----------------------------------------------------------|
| Current                  assets                                                                                                                       |                                                                                   |   |                                                     |
| Cash                                                                                                                                                  | $        6,528                                 |   | $       286,293  |
| Accounts                  receivable, net of allowance of $124,932 and $80,558                                                                        |            44,374               |   | 82,798                                              |
| Prepaid                  and other current assets                                                                                                     | 8,015                                                                                  |   | 24,974                                              |
| Total                  current assets                                                                                                                 | 58,917                                                                                 |   | 394,065                                             |
|                                                                                                                                                  |                                                                                   |   |                                                     |
| Property,                  plant and equipment, net of accumulated depreciation of $149,719                  and                  $134,014            | 150,313                                                                                |   | 150,366                                             |
| Deferred                  financing costs                                                                                                             | 129,236                                                                                |   | 82,050                                              |
| Other                  Assets                                                                                                                         |          -                           |   | 3,569                                               |
|  Total                  assets                                                                                                                   | $        338,466                               |   | $       630,050  |
|                                                                                                                                                  |                                                                                   |   |                                                     |
| LIABILITIES                  AND STOCKHOLDERS’ DEFICIT                                                                                          |                                                                                   |   |
|                                                                                                                                                  |                                                                                   |   |                                                     |
| Current                  liabilities                                                                                                                  |                                                                                   |   |                                                     |
| Accounts                  payable and accrued liabilities                                                                                             | $        417,044                               |   | $       275,000  |
| Stock                  payable                                                                                                                        | 86,774                                                                                 |   | 112,725                                             |
| Notes                  payable - related parties                                                                                                      | 254,928                                                                                |   | 249,808                                             |
| Lines                  of credit                                                                                                                      | 1,122                                                                                  |   | 6,594                                               |
| Mandatorily                  redeemable Series C Preferred Stock, $0.001 par                  value, 90,000 shares authorized, issued and outstanding | 75,600                                                                                 |   | 75,600                                              |
| Derivative                  liabilities                                                                                                               | 239,908                                                                                |   | 103,469                                             |
| Total                  current liabilities                                                                                                            | 1,075,376                                                                              |   | 823,196                                             |
|                                                                                                                                                  |                                                                                   |   |                                                     |
| Callable                  secured convertible notes payable, net                                                                                      | 2,031,092                                                                              |   | 1,433,849                                           |
| Total                  Liabilities                                                                                                                    | 3,106,468                                                                              |   | 2,257,045                                           |
|                                                                                                                                                  |                                                                                   |   |                                                     |
| Stockholders’                  deficit                                                                                                          |                                                                                   |   |                                                     |
| Series                  A Convertible Preferred Stock, $0.001 par value,                                                                              |                                                                                   |   |                                                     |
| 5,000,000                  shares authorized, 0 shares issued and outstanding                                                                         | -                                                                                      |   | -                                                        |
| Series                  B Preferred Stock, $0.001 par value, 5,000,000 shares                                                                         |                                                                                   |   |                                                     |
| authorized,                  0 shares issued and outstanding                                                                                          | -                                                                                      |   | -                                                        |
| Common                  stock, $0.001 par value, 500,000,000 shares authorized,                                                                       |                                                                                   |   |                                                     |
| 93,811,908                  and 76,561,857 shares issued and outstanding                                                                              | 93,811                                                                                 |   | 76,561                                              |
| Additional                  paid-in capital                                                                                                           | 61,886,660                                                                             |   | 61,871,773                                          |
| Accumulated                  deficit                                                                                                                  |       (64,748,473)                                       |   | (63,575,329)                                             |
| Total                  stockholders’ deficit                                                                                                    |          (2,768,002)                      |   |  (1,626,995)                                   |
|                                                                                                                                                  |                                                                                   |   |                                                     |
|  Total                  liabilities and                  stockholders’ deficit                                                             | $                            338,466 |   | $       630,050  |

----

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

**CONSOLIDATED      STATEMENTS OF OPERATIONS**

**(unaudited)**

|                                                  | Three                  Months endedAugust                  31 |       | Six                  Months endedAugust                  31, |   |
|-------------------------------------------------------|---------------------------------------------------------------|------------|--------------------------------------------------------------|--------|
|                                                  | 2007                                                          |       | 2006                                                         |   | 2007 |   | 2006 |   |
|                                                  |                                                          |       |                                                         |   |   |   |   |   |
| Revenues                                              | $                                                             | 126,107    |                                                         | $      | 234,968 |   | $ | 330,042 |   | $ | 369,031 |   |
|                                                  |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
| Operating                  expenses:                  |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
| General                  and Administrative           |                                                          | 691,967    |                                                         |   | 419,189 |   |   | 1,165,848 |   |   | 857,434 |   |
| Depreciation                                          |                                                          | 7,790      |                                                         |   | 1,043 |   |   | 15,705 |   |   | 8,529 |   |
| Net                  loss from operations             |                                                          | (573,650)  |                                                         |   | (185,264) |   |   | (851,511) |   |   | (496,932) |   |
|                                                  |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
| Other                  income and expense:            |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
|                                                  |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
| Gain                  (loss) on derivatives           |                                                          | (107,245)  |                                                         |   | 97,903 |   |   | (70,145) |   |   | 1,055 |   |
| Law                  suit settlement                  |                                                          | -          |                                                         |   | - |   |   | - |   |   | (96,000) |   |
| Registration                  rights penalties        |                                                          | -          |                                                         |   | (48,000) |   |   | - |   |   | - |   |
|                                                  |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
| Interest                  expense                     |                                                          | (126,304)  |                                                         |   | (51,944) |   |   | (251,488) |   |   | (128,891) |   |
|                                                  |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
|  Net                  loss                       | $                                                             | (807,199)  |                                                         | $      | (187,305) |   | $ | (1,173,144) |   | $ | (720,768) |   |
|                                                  |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
| Basic                  and diluted net loss per share | $                                                             | (0.01)     |                                                         | $      | (0.00) |   | $ | (0.01) |   | $ | (0.01) |   |
|                                                  |                                                          |       |                                                         |   |   |   |   |   |   |   |   |   |
| Weighted                  average shares outstanding  |                                                          | 88,578,212 |                                                         |   | 68,974,769 |   |   | 83,560,549 |   |   | 68,867,731 |   |

----

**PAPERFREE      MEDICAL SOLUTIONS, INC.**

**CONSOLIDATED      STATEMENTS OF CASH FLOWS**

**(unaudited)**

|                                                                                                          | Six                    Months EndedAugust                    31, |                                                                                                                         |
|---------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                          | 2007                                                             |                                                                                                                         | 2006 |   |
| CASH                    FLOWS FROM OPERATING ACTIVITIES:                                                      |                                                             |                                                                                                                         |   |   |   |   |
| Net                    loss                                                                                   |                                                             |  $                        (1,173,144)                                                               |   |   | $                          (720,768) |   |
| Adjustments                    to reconcile net loss to cash used in operating                    activities: |                                                             |                                                                                                                         |   |   |   |   |
| Depreciation                                                                                                  |                                                             | 15,705                                                                                                                       |   |   | 8,529 |   |
| Deferred                    financing costs amortization                                                      |                                                             | 30,314                                                                                                                       |   |   | 16,667 |   |
| Convertible                    debt discount amortization                                                     |                                                             | 118,520                                                                                                                      |   |   | 76,289 |   |
| Imputed                    interest                                                                           |                                                             | 7,161                                                                                                                        |   |   | 13,799 |   |
| (Gain)                    loss on derivatives                                                                 |                                                             | 70,145                                                                                                                       |   |   | (1,055) |   |
| Common                    stock issued for service                                                            |                                                             | 5,250                                                                                                                        |   |   | 11,900 |   |
| Employee                    stock options                                                                     |                                                             | 6,430                                                                                                                        |   |   | - |   |
| Changes                    in assets and liabilities:                                                         |                                                             |                                                                                                                         |   |   |   |   |
| Accounts                    receivable                                                                        |                                                             | 38,424                                                                                                                       |   |   | (39,917) |   |
| Prepaid                    and other current assets                                                           |                                                             | 20,528                                                                                                                       |   |   | - |   |
| Deferred                    revenue                                                                           |                                                             | -                                                                                                                            |   |   | 5,000 |   |
| Stock                    payable                                                                              |                                                             | (25,951)                                                                                                                     |   |   | - |   |
| Accounts                    payable and accrued liabilities                                                   |                                                             | 145,357                                                                                                                      |   |   | 376,380 |   |
| CASH                    USED IN OPERATING ACTIVITIES                                                          |                                                             | (741,261)                                                                                                                    |   |   | (253,176) |   |
|                                                                                                          |                                                             |                                                                                                                         |   |   |   |   |
| CASH                    FLOWS FROM INVESTING ACTIVITIES:                                                      |                                                             |                                                                                                                         |   |   |   |   |
| Purchase                    of property, plant and equipment                                                  |                                                             | (15,652)                                                                                                                     |   |   | - |   |
|                                                                                                          |                                                             |                                                                                                                         |   |   |   |   |
| CASH                    FLOWS FROM FINANCING ACTIVITIES:                                                      |                                                             |                                                                                                                         |   |   |   |   |
| Net                    change in line of credit                                                               |                                                             | (5,472)                                                                                                                      |   |   | (3,513) |   |
| Advances                    from related party                                                                |                                                             | 41,724                                                                                                                       |   |   | 65,076 |   |
| Repayment                    of advances to related party                                                     |                                                             | (36,604)                                                                                                                     |   |   | (35,387) |   |
| Proceeds                    from convertible debt, net of offering costs                                      |                                                             | 477,500                                                                                                                      |   |   | 195,000 |   |
| CASH                    PROVIDED BY FINANCING ACTIVITIES                                                      |                                                             | 477,148                                                                                                                      |   |   | 221,176 |   |
|                                                                                                          |                                                             |                                                                                                                         |   |   |   |   |
| NET                    CHANGE IN CASH                                                                         |                                                             | (279,765)                                                                                                                    |   |   | (32,000) |   |
| Cash,                    beginning of period                                                                  |                                                             | 286,293                                                                                                                      |   |   | 213,368 |   |
|  Cash,                    end of period                                                                  |                                                             | $                             6,528                                             |   |   | $                          181,368 |   |
|                                                                                                          |                                                             |                                                                                                                         |   |   |   |   |
| Cash                    paid for:                                                                             |                                                             |                                                                                                                         |   |   |   |   |
| Interest                                                                                                      |                                                             | $                                     - |   |   | $                            36,301 |   |
| Taxes                                                                                                         |                                                             | -                                                                                                                            |   |   | - |   |
|                                                                                                          |                                                             |                                                                                                                         |   |   |   |   |
|  NON-CASH                    INVESTING AND FINANCING ACTIVITIES:                                         |                                                             |                                                                                                                         |   |   |   |   |
|                                                                                                          |                                                             |                                                                                                                         |   |   |   |   |
| Conversion                    of note payable to common stock                                                 |                                                             | $        13,297                                                                      |   |   | $                                      - |   |
| Discount                    on convertible debt from derivatives                                              |                                                             | 66,294                                                                                                                       |   |   | 54,295 |   |

----

**PAPERFREE        MEDICAL SOLUTIONS, INC.**

**NOTES        TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**NOTE        1 - BASIS OF PRESENTATION**

**NOTE        2 - CALLABLE SECURED CONVERTIBLE NOTES PAYABLE**

| 1.   | $800,000                  on November 30, 2005 due November 30, 2008, and 1,600,000 warrants                  to                  purchase common stock at an exercise price of $0.10 per                  share; |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2.   | $200,000                  on August 31, 2006 due August 31, 2009, and 400,000 warrants to                  purchase                  common stock at an exercise price of $0.10 per                  share; |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.   | $200,000                  on October 27, 2006 due October 27, 2009, and 400,000 warrants                  to purchase                  common stock at an exercise price of $0.10 per                  share; |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4.   | $300,000                  on December 12, 2006 due December 12, 2009, and 600,000 warrants                  to                  purchase common stock at an exercise price of $0.10 per                  share; |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5.   | $500,000                  on February 7, 2007 due February 10, 2010 and 5,000,000 warrants                  to                  purchase common stock at an exercise price of $0.01 per                  share. |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |                    6. | $330,000                  on May 31, 2007 due May 31, 2010 and 5,000,000 warrants to purchase                  common                  stock at an exercise price of $0.01 per                  share. |
|--------|----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |                    7. | $249,750                  on July 24, 2007 due July 24, 2014 and 20,000,000 warrants to purchase                  common stock at an exercise price of $.0012 per                  share. |
|--------|----------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Debt                  arrangement fees                 | $  117,500       |
|--------------------------------------------------------|----------------------------|
| Broker                  fees                           | 45,000                     |
| Key                  man life insurance single premium |  20,000               |
| Legal                  fees                            | 15,000                     |
| Less:                  amortization                    | (68,264)                   |
|  Deferred                  financing costs        | $                  129,236 |

|                                 | Liability                    as ofFebruary                    28, 2007                |   | Discount                    related toadditional                    financing   |   | Gain/Loss                    for the six months endedAugust                    31, 2007 |   | Liability                    as ofAugust                    31, 2007 |
|--------------------------------------|---------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------|--------|----------------------------------------------------------------------|
| Convertible                    notes | $             71,936 |   | $            46,415 |   | $          95,066                     |   | $        213,417             |
| Warrants                             | 31,533                                                                                |   | 19,879                                                                          |   | (24,921)                                                                                |   | 26,491                                                               |
| Total                                | $           103,469            |   | $            66,294 |   | $          70,145                     |   | $        239,908             |

| Face                  value of convertible notes                                                                                 | $     2,579,750  |
|----------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------|
| Adjustments:                                                                                                                     |                                           |
| Discount                  for derivative liability – convertible notes with compound embedded                  derivatives | (669,728)                                      |
| Discount                  for derivative liability – investors warrant                                                     | (164,508)                                      |
| Conversion                                                                                                                       | (25,456)                                       |
| Cash                  discount                                                                                                   | (24,750)                                       |
| Amortization                  of debt discount                                                                                   | 335,783                                        |
| Convertible                  notes balance, net                                                                                  | $     2,031,091       |

**NOTE        3 - COMMON STOCK**

**NOTE        4 – WARRANTS AND OPTIONS**

|                                                  |   | Warrants   |   | Weighted                      average exercise                      price |   | Aggregate intrinsic                      value |   | Weighted                      Average remainingcontractual                      life (years) |
|-------------------------------------------------------|--------|------------|--------|--------------------------------------------------------------------------------|--------|-----------------------------------------------------|--------|----------------------------------------------------------------------------------------------|
| Outstanding                      at February 28, 2007 |   | 6,519,600  |   | $                      0.08                                                    |   |                                                |   |                                                                                         |
| Granted                                               |   | 26,500,000 |   | 0.01                                                                           |   |                                                |   |                                                                                         |
| Exercised                                             |   | -          |   | -                                                                              |   |                                                |   |                                                                                         |
| Forfeited                      /Expired               |   | -          |   | -                                                                              |   |                                                |   |                                                                                         |
|                                                  |   |       |   |                                                                           |   |                                                |   |                                                                                         |
| Outstanding                      at August 31, 2007   |   | 33,019,600 |   | $0.01                                                                          |   | $  596,810                                |   | 7.0                                                                                          |
|                                                  |   |       |   |                                                                           |   |                                                |   |                                                                                         |
| Exercisable                      at August 31, 2007   |   | 33,019,600 |   |                                                                           |   |                                                |   |                                                                                         |

**NOTE        5 - CONTINGENCIES**

**NOTE        6 – NEW ACCOUNTING PRONOUNCEMENTS**

**NOTE        7 – SUBSEQUENT EVENTS**

**ITEM        2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF        OPERATIONS.**

**EXECUTIVE        OVERVIEW**

| ·   | MDPaperFreeTM                  - This service offering is a service bureau providing integrated                  digital office technologies to the medical provider practice on                  a managed                  services provisioning (“MSP”) basis. The technologies provided include,                  but are not limited to:  a) Electronic Medical Record; b) Secure                  Document Management; c) Office Productivity Tools; d) Internet                  Presence;                  e) Data and Computing Security; f) Information Security; and g)                  Back-up/Restore/Contingency                  Services. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | LEAPprn                  - This service offering provides three categories of revenue                  cycle                  management services:  a) Complete billing management services;                  b) Shared billing management services wherein the client performs                  data                  entry only; and, c) Licensed/Hosted billing management software                  wherein                  the client performs all data and payer business processes using                  our                  software. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

**BUSINESS        ENVIRONMENT**

| ·   | Operations |
|--------------------|------------|

| ·   | Financial |
|--------------------|-----------|

**Facilities:**

**Sales        & Marketing:**

**Personnel:**

**Legal-Regulatory:**

**Governance:**

Financial

**MANAGEMENT        SUMMARY**

**RESULTS        OF OPERATIONS**

***Three        months ended August 31, 2007 vs. 2006***

***Six        months ended August 31, 2007 vs. 2006***

**LIQUIDITY        AND CAPITAL RESOURCES**

**Risk        Factors**

**Unsuccessful        Operating History**

**If        We Do Not Obtain Additional        Financing, We Will Not Be Able to Acquire Any        Assets**

|   | *  | Market                  conditions;                               |
|--------|---------|------------------------------------------------------------------------|
|   | *  | Investor                  acceptance of potential business assets; and |
|   | *  | Investor                  sentiment.                              |

**If        We Are Unable To Generate Significant Revenues From Our Operations, Our Business        Will Fail.**

**Our        Securities May Be Subject to Penny Stock Regulation.**

**Forward-Looking        Statements**

**ITEM        3. CONTROLS AND PROCEDURES**

**PART        II**

**ITEM        1 - LEGAL PROCEEDINGS**

**ITEM        2 - CHANGES IN SECURITIES**

**ITEM        3 - DEFAULTS UPON SENIOR SECURITIES**

**ITEM        4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS**

**ITEM        5 - OTHER INFORMATION**

**ITEM        6 - EXHIBITS AND REPORTS ON FORM 8-K**

| Exhibit | Description                of Exhibit                                                                                                            |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.1    | Certification                of Chief Executive Officer Pursuant to Rule                13a-14(a)/15d-14(a)                                      |
| 31.2    | Certification                of Chief Financial Officer Pursuant to Rule                13a-14(a)/l5d-14(a)                                      |
| 32.1    | Certification                of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley                Act of 2002, 18 U.S.C. 1350 |
| 32.2    | Certification                of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley                Act of 2002, 18 U.S.C. 1350 |

----

**SIGNATURES**

**PAPERFREE      MEDICAL SOLUTIONS, INC**

|                                                         |   |   |                                                         |   |
|--------------------------------------------------------------|--------|--------|--------------------------------------------------------------|--------|
| /s/Stephen                Hawksworth                         |   |   | /s/                Craig S.                Barrow            |   |
| Name:Stephen                Hawksworth                       |   |   | Name:                 Craig S. Barrow                   |   |
| Title:                Chief                Executive Officer |   |   | Title:                Chief                Financial Officer |   |